Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immunity, Innate | 17 | 2021 | 409 | 3.470 |
Why?
|
Selection, Genetic | 19 | 2024 | 502 | 3.070 |
Why?
|
Mycobacterium tuberculosis | 19 | 2023 | 186 | 3.050 |
Why?
|
Genetics, Population | 12 | 2020 | 394 | 2.780 |
Why?
|
Tuberculosis | 14 | 2023 | 110 | 2.610 |
Why?
|
Epigenesis, Genetic | 11 | 2024 | 479 | 2.460 |
Why?
|
Evolution, Molecular | 15 | 2018 | 813 | 1.920 |
Why?
|
Lectins, C-Type | 8 | 2009 | 85 | 1.840 |
Why?
|
Immunologic Memory | 4 | 2021 | 152 | 1.600 |
Why?
|
Primates | 3 | 2021 | 151 | 1.600 |
Why?
|
Cell Adhesion Molecules | 7 | 2009 | 163 | 1.500 |
Why?
|
Immune System | 4 | 2020 | 93 | 1.490 |
Why?
|
Receptors, Cell Surface | 7 | 2009 | 286 | 1.430 |
Why?
|
Genome, Human | 14 | 2024 | 756 | 1.430 |
Why?
|
Dendritic Cells | 10 | 2019 | 425 | 1.420 |
Why?
|
Bacteria | 6 | 2023 | 447 | 1.420 |
Why?
|
Macrophages | 8 | 2023 | 554 | 1.360 |
Why?
|
Genetic Variation | 15 | 2021 | 1351 | 1.330 |
Why?
|
Papio | 6 | 2023 | 82 | 1.270 |
Why?
|
Gastrointestinal Microbiome | 8 | 2023 | 455 | 1.230 |
Why?
|
Genetic Predisposition to Disease | 14 | 2022 | 2271 | 1.200 |
Why?
|
Immunity | 6 | 2022 | 136 | 1.120 |
Why?
|
Lactase | 2 | 2024 | 5 | 1.120 |
Why?
|
Influenza, Human | 3 | 2024 | 329 | 1.110 |
Why?
|
Animals | 58 | 2024 | 26582 | 1.070 |
Why?
|
Host-Pathogen Interactions | 6 | 2021 | 231 | 1.060 |
Why?
|
Leukocytes, Mononuclear | 5 | 2021 | 196 | 1.050 |
Why?
|
Gene Expression Regulation | 16 | 2023 | 1920 | 0.970 |
Why?
|
Humans | 104 | 2024 | 86645 | 0.970 |
Why?
|
Gene Expression Profiling | 11 | 2021 | 1384 | 0.940 |
Why?
|
Immunity, Cellular | 3 | 2016 | 177 | 0.930 |
Why?
|
Bacterial Infections | 7 | 2023 | 182 | 0.910 |
Why?
|
Adaptation, Physiological | 5 | 2021 | 306 | 0.840 |
Why?
|
Tuberculosis, Pulmonary | 4 | 2016 | 58 | 0.790 |
Why?
|
Biological Evolution | 6 | 2024 | 919 | 0.780 |
Why?
|
Mycobacterium bovis | 2 | 2018 | 16 | 0.770 |
Why?
|
Quantitative Trait Loci | 11 | 2024 | 576 | 0.760 |
Why?
|
Hematopoietic Stem Cells | 3 | 2023 | 292 | 0.760 |
Why?
|
Immunity, Herd | 1 | 2020 | 2 | 0.760 |
Why?
|
Autoimmune Diseases | 3 | 2023 | 241 | 0.750 |
Why?
|
Viruses | 1 | 2021 | 78 | 0.750 |
Why?
|
Multifactorial Inheritance | 2 | 2019 | 159 | 0.750 |
Why?
|
Sepsis | 2 | 2021 | 306 | 0.740 |
Why?
|
Polymorphism, Single Nucleotide | 16 | 2024 | 2357 | 0.730 |
Why?
|
Models, Immunological | 1 | 2020 | 80 | 0.730 |
Why?
|
Environment | 1 | 2021 | 219 | 0.710 |
Why?
|
Genetic Loci | 5 | 2017 | 250 | 0.690 |
Why?
|
Energy Metabolism | 1 | 2021 | 271 | 0.680 |
Why?
|
Genome | 6 | 2024 | 372 | 0.670 |
Why?
|
Gene Expression | 4 | 2019 | 1284 | 0.670 |
Why?
|
Macaca mulatta | 8 | 2022 | 459 | 0.660 |
Why?
|
DNA, Mitochondrial | 1 | 2019 | 183 | 0.640 |
Why?
|
Signal Transduction | 10 | 2021 | 3241 | 0.630 |
Why?
|
DNA Copy Number Variations | 1 | 2019 | 171 | 0.620 |
Why?
|
Rainforest | 6 | 2019 | 8 | 0.610 |
Why?
|
Latent Tuberculosis | 1 | 2017 | 16 | 0.610 |
Why?
|
Chiroptera | 1 | 2018 | 51 | 0.610 |
Why?
|
Epigenomics | 5 | 2024 | 100 | 0.580 |
Why?
|
Transcriptome | 5 | 2021 | 580 | 0.580 |
Why?
|
Social Class | 1 | 2016 | 128 | 0.560 |
Why?
|
Toll-Like Receptors | 4 | 2013 | 92 | 0.560 |
Why?
|
Leprosy | 3 | 2017 | 8 | 0.550 |
Why?
|
Microbiota | 4 | 2024 | 381 | 0.550 |
Why?
|
Heart | 1 | 2018 | 539 | 0.540 |
Why?
|
DNA Methylation | 6 | 2024 | 628 | 0.540 |
Why?
|
Base Pairing | 1 | 2015 | 55 | 0.530 |
Why?
|
Cytosine | 2 | 2015 | 127 | 0.530 |
Why?
|
Inflammation | 8 | 2023 | 920 | 0.520 |
Why?
|
Social Behavior | 4 | 2022 | 294 | 0.520 |
Why?
|
Celiac Disease | 5 | 2020 | 203 | 0.520 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 316 | 0.510 |
Why?
|
Coronavirus Infections | 1 | 2020 | 301 | 0.510 |
Why?
|
RNA, Untranslated | 3 | 2011 | 63 | 0.510 |
Why?
|
Immunogenetic Phenomena | 1 | 2014 | 5 | 0.510 |
Why?
|
Chromatin | 4 | 2024 | 380 | 0.490 |
Why?
|
Antiviral Agents | 1 | 2018 | 510 | 0.490 |
Why?
|
Gene Flow | 4 | 2019 | 88 | 0.490 |
Why?
|
Sequence Analysis, DNA | 11 | 2022 | 853 | 0.490 |
Why?
|
Disease Susceptibility | 5 | 2023 | 193 | 0.480 |
Why?
|
Prefrontal Cortex | 1 | 2015 | 129 | 0.480 |
Why?
|
Macrophages, Alveolar | 3 | 2023 | 55 | 0.470 |
Why?
|
Plague | 2 | 2023 | 27 | 0.450 |
Why?
|
Adenosine Triphosphate | 1 | 2014 | 314 | 0.440 |
Why?
|
Mycobacterium leprae | 3 | 2017 | 6 | 0.440 |
Why?
|
Chytridiomycota | 1 | 2012 | 2 | 0.440 |
Why?
|
Lipopolysaccharides | 5 | 2023 | 286 | 0.440 |
Why?
|
Ranidae | 1 | 2012 | 5 | 0.440 |
Why?
|
Feces | 6 | 2021 | 319 | 0.430 |
Why?
|
Xenopus | 1 | 2012 | 125 | 0.430 |
Why?
|
Periodicals as Topic | 1 | 2014 | 168 | 0.420 |
Why?
|
Mitogen-Activated Protein Kinase Phosphatases | 1 | 2012 | 2 | 0.420 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2012 | 4 | 0.420 |
Why?
|
Transcription, Genetic | 8 | 2021 | 1135 | 0.420 |
Why?
|
Mycoses | 1 | 2012 | 46 | 0.420 |
Why?
|
Transcription Factors | 9 | 2023 | 1565 | 0.420 |
Why?
|
MicroRNAs | 3 | 2015 | 534 | 0.410 |
Why?
|
NFATC Transcription Factors | 1 | 2011 | 29 | 0.410 |
Why?
|
Immune System Diseases | 2 | 2023 | 26 | 0.400 |
Why?
|
Gene-Environment Interaction | 3 | 2024 | 103 | 0.400 |
Why?
|
Gene Frequency | 4 | 2024 | 677 | 0.390 |
Why?
|
Male | 30 | 2021 | 40967 | 0.390 |
Why?
|
Adaptive Immunity | 3 | 2021 | 164 | 0.390 |
Why?
|
Glutens | 4 | 2020 | 76 | 0.380 |
Why?
|
Female | 31 | 2022 | 44534 | 0.380 |
Why?
|
Genomics | 2 | 2024 | 720 | 0.380 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2021 | 425 | 0.370 |
Why?
|
Immune Tolerance | 4 | 2021 | 337 | 0.360 |
Why?
|
Quantitative Trait, Heritable | 1 | 2010 | 124 | 0.360 |
Why?
|
Gene Ontology | 4 | 2018 | 34 | 0.350 |
Why?
|
Cell Nucleus | 1 | 2011 | 579 | 0.350 |
Why?
|
Interleukin-15 | 2 | 2020 | 72 | 0.350 |
Why?
|
Species Specificity | 4 | 2021 | 678 | 0.350 |
Why?
|
Computational Biology | 3 | 2018 | 528 | 0.340 |
Why?
|
HIV-1 | 2 | 2008 | 163 | 0.340 |
Why?
|
Molecular Probes | 1 | 2009 | 35 | 0.340 |
Why?
|
Skin | 1 | 2012 | 554 | 0.340 |
Why?
|
Colitis | 1 | 2011 | 239 | 0.330 |
Why?
|
Lymphocyte Activation | 2 | 2021 | 728 | 0.330 |
Why?
|
High-Throughput Screening Assays | 1 | 2009 | 55 | 0.330 |
Why?
|
Promoter Regions, Genetic | 3 | 2014 | 937 | 0.320 |
Why?
|
Phenotype | 5 | 2021 | 2378 | 0.320 |
Why?
|
Genotype | 7 | 2021 | 1851 | 0.320 |
Why?
|
HIV Infections | 3 | 2021 | 772 | 0.320 |
Why?
|
Agriculture | 3 | 2019 | 38 | 0.310 |
Why?
|
Metagenome | 2 | 2022 | 102 | 0.310 |
Why?
|
Receptors, Antigen, T-Cell | 4 | 2022 | 372 | 0.300 |
Why?
|
Mitochondria | 2 | 2022 | 535 | 0.290 |
Why?
|
Pan troglodytes | 3 | 2021 | 197 | 0.290 |
Why?
|
Seasons | 2 | 2021 | 223 | 0.290 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2006 | 147 | 0.290 |
Why?
|
Regulatory Sequences, Nucleic Acid | 4 | 2020 | 148 | 0.290 |
Why?
|
Mice, Inbred C57BL | 8 | 2022 | 3092 | 0.290 |
Why?
|
Microglia | 2 | 2017 | 102 | 0.280 |
Why?
|
Mice | 15 | 2023 | 11352 | 0.280 |
Why?
|
Symbiosis | 2 | 2024 | 118 | 0.270 |
Why?
|
Cells, Cultured | 5 | 2018 | 2818 | 0.270 |
Why?
|
Orthomyxoviridae Infections | 2 | 2023 | 46 | 0.270 |
Why?
|
Chromosome Mapping | 2 | 2024 | 1074 | 0.260 |
Why?
|
Gastrointestinal Tract | 3 | 2020 | 191 | 0.260 |
Why?
|
Adult | 14 | 2021 | 25648 | 0.260 |
Why?
|
Antigens, Bacterial | 2 | 2017 | 134 | 0.260 |
Why?
|
Monocytes | 3 | 2017 | 214 | 0.250 |
Why?
|
Influenza A virus | 2 | 2023 | 169 | 0.250 |
Why?
|
Uganda | 3 | 2019 | 34 | 0.250 |
Why?
|
Vaccination | 3 | 2021 | 254 | 0.250 |
Why?
|
BCG Vaccine | 2 | 2021 | 31 | 0.250 |
Why?
|
Neanderthals | 2 | 2021 | 15 | 0.240 |
Why?
|
Cell Line | 7 | 2019 | 2468 | 0.240 |
Why?
|
DNA Transposable Elements | 2 | 2020 | 169 | 0.240 |
Why?
|
CpG Islands | 3 | 2019 | 151 | 0.240 |
Why?
|
Pluripotent Stem Cells | 1 | 2023 | 31 | 0.240 |
Why?
|
Behavior, Animal | 3 | 2019 | 373 | 0.240 |
Why?
|
Diet | 3 | 2022 | 443 | 0.230 |
Why?
|
Individuality | 1 | 2024 | 109 | 0.230 |
Why?
|
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | 1 | 2023 | 2 | 0.230 |
Why?
|
GATA4 Transcription Factor | 1 | 2023 | 17 | 0.230 |
Why?
|
Virus Diseases | 3 | 2019 | 97 | 0.230 |
Why?
|
Cell Self Renewal | 1 | 2023 | 18 | 0.230 |
Why?
|
Farmers | 3 | 2019 | 5 | 0.220 |
Why?
|
Killer Cells, Natural | 3 | 2022 | 267 | 0.220 |
Why?
|
Cholangitis, Sclerosing | 1 | 2023 | 52 | 0.220 |
Why?
|
Enterobacteriaceae Infections | 1 | 2023 | 23 | 0.220 |
Why?
|
Environmental Exposure | 2 | 2024 | 296 | 0.220 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2022 | 456 | 0.220 |
Why?
|
Yersinia pestis | 1 | 2022 | 24 | 0.220 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2022 | 17 | 0.220 |
Why?
|
Interleukins | 2 | 2022 | 134 | 0.220 |
Why?
|
DNA, Ancient | 1 | 2022 | 18 | 0.220 |
Why?
|
Lymphopenia | 1 | 2022 | 28 | 0.220 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2022 | 559 | 0.220 |
Why?
|
DNA-Binding Proteins | 2 | 2018 | 1208 | 0.210 |
Why?
|
Intestinal Mucosa | 3 | 2023 | 797 | 0.210 |
Why?
|
Heredity | 1 | 2022 | 19 | 0.210 |
Why?
|
Lymphocytic Choriomeningitis | 1 | 2021 | 8 | 0.210 |
Why?
|
Mutation | 8 | 2018 | 3968 | 0.210 |
Why?
|
Phylogeny | 5 | 2017 | 1137 | 0.210 |
Why?
|
Actinobacteria | 1 | 2021 | 11 | 0.200 |
Why?
|
Firmicutes | 1 | 2021 | 14 | 0.200 |
Why?
|
Hematopoiesis | 2 | 2023 | 163 | 0.200 |
Why?
|
Cell Differentiation | 3 | 2023 | 1458 | 0.200 |
Why?
|
Life Style | 2 | 2019 | 189 | 0.200 |
Why?
|
Neutrophils | 1 | 2023 | 307 | 0.200 |
Why?
|
Binding Sites | 4 | 2018 | 1098 | 0.200 |
Why?
|
Bacteroidetes | 1 | 2021 | 37 | 0.200 |
Why?
|
Lung | 3 | 2023 | 1170 | 0.200 |
Why?
|
Myelopoiesis | 1 | 2020 | 10 | 0.190 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2021 | 102 | 0.190 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2014 | 302 | 0.190 |
Why?
|
Histones | 1 | 2023 | 311 | 0.190 |
Why?
|
Social Dominance | 2 | 2022 | 30 | 0.190 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2021 | 132 | 0.190 |
Why?
|
Case-Control Studies | 6 | 2019 | 1805 | 0.190 |
Why?
|
Vaccination Coverage | 1 | 2020 | 5 | 0.190 |
Why?
|
Adaptation, Biological | 2 | 2019 | 85 | 0.190 |
Why?
|
Basic Reproduction Number | 1 | 2020 | 6 | 0.190 |
Why?
|
Population | 4 | 2011 | 35 | 0.190 |
Why?
|
Glucocorticoids | 2 | 2022 | 352 | 0.180 |
Why?
|
Primate Diseases | 1 | 2019 | 4 | 0.180 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2019 | 12 | 0.180 |
Why?
|
Lentivirus | 1 | 2019 | 36 | 0.180 |
Why?
|
HLA-DQ Antigens | 1 | 2020 | 52 | 0.180 |
Why?
|
Cell Proliferation | 4 | 2020 | 1578 | 0.180 |
Why?
|
Interferon Regulatory Factor-1 | 2 | 2017 | 19 | 0.180 |
Why?
|
Fecal Microbiota Transplantation | 1 | 2020 | 62 | 0.180 |
Why?
|
Software | 1 | 2024 | 654 | 0.180 |
Why?
|
Antigens | 2 | 2019 | 228 | 0.180 |
Why?
|
Alleles | 6 | 2021 | 1128 | 0.180 |
Why?
|
DNA Demethylation | 1 | 2019 | 1 | 0.170 |
Why?
|
Transduction, Genetic | 1 | 2019 | 153 | 0.170 |
Why?
|
Benzodiazepines | 1 | 2019 | 65 | 0.170 |
Why?
|
T-Lymphocyte Subsets | 1 | 2021 | 272 | 0.170 |
Why?
|
Genome-Wide Association Study | 4 | 2015 | 1621 | 0.170 |
Why?
|
Antibodies | 1 | 2021 | 350 | 0.170 |
Why?
|
Principal Component Analysis | 2 | 2017 | 155 | 0.170 |
Why?
|
Transcriptional Activation | 1 | 2020 | 280 | 0.170 |
Why?
|
Global Health | 1 | 2020 | 193 | 0.170 |
Why?
|
Egypt | 1 | 2018 | 13 | 0.170 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2018 | 69 | 0.160 |
Why?
|
Growth Hormone | 1 | 2018 | 97 | 0.160 |
Why?
|
Acclimatization | 1 | 2018 | 76 | 0.160 |
Why?
|
Bayes Theorem | 3 | 2015 | 361 | 0.160 |
Why?
|
Genetic Heterogeneity | 1 | 2018 | 62 | 0.160 |
Why?
|
Genetic Vectors | 1 | 2019 | 439 | 0.160 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2019 | 102 | 0.160 |
Why?
|
Bacterial Physiological Phenomena | 1 | 2018 | 40 | 0.160 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 41 | 0.160 |
Why?
|
Chronic Disease | 3 | 2019 | 971 | 0.160 |
Why?
|
Acetylmuramyl-Alanyl-Isoglutamine | 1 | 2017 | 4 | 0.160 |
Why?
|
Protein Binding | 3 | 2021 | 1456 | 0.160 |
Why?
|
RNA, Double-Stranded | 1 | 2017 | 22 | 0.160 |
Why?
|
5-Methylcytosine | 2 | 2015 | 112 | 0.160 |
Why?
|
alpha7 Nicotinic Acetylcholine Receptor | 1 | 2017 | 21 | 0.150 |
Why?
|
France | 1 | 2017 | 47 | 0.150 |
Why?
|
Reoviridae Infections | 1 | 2017 | 7 | 0.150 |
Why?
|
Exome | 1 | 2018 | 127 | 0.150 |
Why?
|
Middle Aged | 7 | 2021 | 25028 | 0.150 |
Why?
|
RNA, Messenger | 3 | 2019 | 1981 | 0.150 |
Why?
|
Interferon-gamma | 3 | 2020 | 444 | 0.150 |
Why?
|
2',5'-Oligoadenylate Synthetase | 1 | 2016 | 9 | 0.150 |
Why?
|
Epithelial Cells | 1 | 2021 | 669 | 0.150 |
Why?
|
Abnormalities, Multiple | 1 | 2018 | 232 | 0.150 |
Why?
|
Base Sequence | 5 | 2016 | 2330 | 0.150 |
Why?
|
Betacoronavirus | 1 | 2020 | 258 | 0.150 |
Why?
|
Models, Genetic | 6 | 2014 | 926 | 0.150 |
Why?
|
Cluster Analysis | 2 | 2015 | 369 | 0.150 |
Why?
|
Population Dynamics | 3 | 2018 | 130 | 0.150 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2023 | 549 | 0.150 |
Why?
|
Molecular Sequence Data | 6 | 2014 | 3030 | 0.140 |
Why?
|
Brain | 2 | 2017 | 2216 | 0.140 |
Why?
|
Alu Elements | 1 | 2016 | 15 | 0.140 |
Why?
|
Transforming Growth Factor beta | 1 | 2018 | 301 | 0.140 |
Why?
|
Aging | 1 | 2021 | 691 | 0.140 |
Why?
|
Leukocyte Count | 1 | 2016 | 220 | 0.140 |
Why?
|
Animals, Wild | 1 | 2016 | 40 | 0.140 |
Why?
|
Pituitary-Adrenal System | 1 | 2016 | 64 | 0.140 |
Why?
|
Adjuvants, Immunologic | 1 | 2017 | 167 | 0.140 |
Why?
|
South Africa | 2 | 2006 | 60 | 0.140 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2016 | 81 | 0.140 |
Why?
|
Toll-Like Receptor 4 | 1 | 2016 | 88 | 0.140 |
Why?
|
Th1 Cells | 1 | 2017 | 164 | 0.140 |
Why?
|
Astrocytes | 1 | 2016 | 139 | 0.140 |
Why?
|
Exons | 2 | 2015 | 450 | 0.140 |
Why?
|
Toll-Like Receptor 2 | 2 | 2018 | 33 | 0.140 |
Why?
|
Mycobacterium smegmatis | 1 | 2015 | 6 | 0.140 |
Why?
|
Yersinia pseudotuberculosis | 1 | 2015 | 6 | 0.140 |
Why?
|
Staphylococcus epidermidis | 1 | 2015 | 14 | 0.140 |
Why?
|
Specimen Handling | 1 | 2016 | 98 | 0.140 |
Why?
|
Leukemia | 1 | 2018 | 320 | 0.140 |
Why?
|
Cell Cycle Proteins | 1 | 2018 | 388 | 0.140 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 188 | 0.140 |
Why?
|
Salmonella typhimurium | 1 | 2015 | 32 | 0.140 |
Why?
|
Leukocytes | 1 | 2016 | 202 | 0.130 |
Why?
|
HLA Antigens | 1 | 2017 | 232 | 0.130 |
Why?
|
X Chromosome Inactivation | 1 | 2015 | 28 | 0.130 |
Why?
|
Interferon Regulatory Factors | 1 | 2016 | 67 | 0.130 |
Why?
|
Language | 1 | 2017 | 151 | 0.130 |
Why?
|
Chromosomes, Human | 1 | 2015 | 66 | 0.130 |
Why?
|
Colorectal Neoplasms | 1 | 2023 | 938 | 0.130 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2022 | 878 | 0.130 |
Why?
|
Annexin A1 | 1 | 2014 | 5 | 0.130 |
Why?
|
Virus Physiological Phenomena | 1 | 2014 | 8 | 0.130 |
Why?
|
Personality | 1 | 2016 | 134 | 0.130 |
Why?
|
Interferon Type I | 3 | 2021 | 175 | 0.130 |
Why?
|
Haplotypes | 6 | 2016 | 642 | 0.130 |
Why?
|
Cross-Priming | 1 | 2014 | 48 | 0.130 |
Why?
|
Hydrocortisone | 1 | 2016 | 298 | 0.130 |
Why?
|
Cell Transplantation | 1 | 2014 | 47 | 0.130 |
Why?
|
Zoonoses | 1 | 2014 | 26 | 0.130 |
Why?
|
Phagocytosis | 1 | 2014 | 85 | 0.130 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily C | 1 | 2014 | 7 | 0.130 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily D | 1 | 2014 | 7 | 0.130 |
Why?
|
Young Adult | 3 | 2021 | 5976 | 0.120 |
Why?
|
Proto-Oncogene Proteins | 1 | 2018 | 645 | 0.120 |
Why?
|
Introns | 1 | 2015 | 289 | 0.120 |
Why?
|
Metagenomics | 1 | 2015 | 83 | 0.120 |
Why?
|
Receptors, Purinergic P1 | 1 | 2014 | 3 | 0.120 |
Why?
|
Anxiety | 1 | 2016 | 287 | 0.120 |
Why?
|
Growth Disorders | 1 | 2014 | 63 | 0.120 |
Why?
|
Adenosine Monophosphate | 1 | 2014 | 27 | 0.120 |
Why?
|
Dog Diseases | 1 | 2014 | 35 | 0.120 |
Why?
|
Polymorphism, Genetic | 2 | 2009 | 819 | 0.120 |
Why?
|
Forests | 1 | 2014 | 20 | 0.120 |
Why?
|
Body Size | 1 | 2014 | 91 | 0.120 |
Why?
|
Pandemics | 1 | 2020 | 740 | 0.120 |
Why?
|
Interferons | 2 | 2011 | 133 | 0.120 |
Why?
|
Arnold-Chiari Malformation | 1 | 2014 | 43 | 0.120 |
Why?
|
Social Environment | 1 | 2015 | 188 | 0.120 |
Why?
|
Cytoplasm | 1 | 2014 | 281 | 0.120 |
Why?
|
Gorilla gorilla | 1 | 2013 | 41 | 0.110 |
Why?
|
High Mobility Group Proteins | 1 | 2013 | 26 | 0.110 |
Why?
|
Nerve Degeneration | 1 | 2013 | 83 | 0.110 |
Why?
|
Sex Characteristics | 1 | 2015 | 319 | 0.110 |
Why?
|
Protein Processing, Post-Translational | 1 | 2015 | 371 | 0.110 |
Why?
|
Kinetics | 2 | 2020 | 1513 | 0.110 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2013 | 85 | 0.110 |
Why?
|
Ecosystem | 1 | 2015 | 316 | 0.110 |
Why?
|
Phagosomes | 1 | 2012 | 39 | 0.110 |
Why?
|
Membrane Microdomains | 1 | 2012 | 54 | 0.110 |
Why?
|
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 1 | 2011 | 4 | 0.100 |
Why?
|
Lysosomes | 1 | 2012 | 104 | 0.100 |
Why?
|
Codon, Nonsense | 1 | 2011 | 41 | 0.100 |
Why?
|
Armadillo Domain Proteins | 1 | 2011 | 3 | 0.100 |
Why?
|
Toll-Like Receptor 1 | 1 | 2011 | 6 | 0.100 |
Why?
|
Receptors, Interleukin-1 | 1 | 2011 | 11 | 0.100 |
Why?
|
Toll-Like Receptor 6 | 1 | 2011 | 5 | 0.100 |
Why?
|
Necrosis | 2 | 2023 | 204 | 0.100 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2011 | 49 | 0.100 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2011 | 47 | 0.100 |
Why?
|
Receptors, Interferon | 1 | 2011 | 31 | 0.100 |
Why?
|
Intestine, Small | 2 | 2023 | 303 | 0.100 |
Why?
|
DNA Primers | 2 | 2009 | 543 | 0.100 |
Why?
|
Genetic Linkage | 1 | 2013 | 623 | 0.100 |
Why?
|
Bone Marrow Cells | 2 | 2023 | 253 | 0.100 |
Why?
|
Proteomics | 1 | 2012 | 212 | 0.100 |
Why?
|
Organ Transplantation | 1 | 2014 | 265 | 0.100 |
Why?
|
Linear Models | 1 | 2012 | 421 | 0.090 |
Why?
|
RNA, Long Noncoding | 1 | 2011 | 102 | 0.090 |
Why?
|
Mutation, Missense | 1 | 2011 | 276 | 0.090 |
Why?
|
Cytoskeletal Proteins | 1 | 2011 | 223 | 0.090 |
Why?
|
Cystathionine beta-Synthase | 1 | 2009 | 3 | 0.090 |
Why?
|
Sperm Count | 1 | 2009 | 9 | 0.090 |
Why?
|
Ferredoxin-NADP Reductase | 1 | 2009 | 15 | 0.090 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2009 | 26 | 0.090 |
Why?
|
Human Migration | 2 | 2021 | 25 | 0.090 |
Why?
|
Gene Regulatory Networks | 1 | 2012 | 296 | 0.090 |
Why?
|
Epistasis, Genetic | 1 | 2009 | 86 | 0.090 |
Why?
|
Folic Acid | 1 | 2009 | 60 | 0.090 |
Why?
|
Grooming | 2 | 2022 | 17 | 0.090 |
Why?
|
Biodiversity | 3 | 2016 | 197 | 0.090 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2023 | 241 | 0.080 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2009 | 49 | 0.080 |
Why?
|
HEK293 Cells | 3 | 2019 | 615 | 0.080 |
Why?
|
Membrane Glycoproteins | 1 | 2011 | 428 | 0.080 |
Why?
|
Mumps | 1 | 2008 | 2 | 0.080 |
Why?
|
Mumps virus | 1 | 2008 | 3 | 0.080 |
Why?
|
Somatotrophs | 1 | 2008 | 1 | 0.080 |
Why?
|
Transcription Factor Pit-1 | 1 | 2008 | 6 | 0.080 |
Why?
|
Growth Hormone-Releasing Hormone | 1 | 2008 | 7 | 0.080 |
Why?
|
Iron | 2 | 2020 | 164 | 0.080 |
Why?
|
Population Groups | 1 | 2008 | 41 | 0.080 |
Why?
|
Tunisia | 1 | 2007 | 8 | 0.080 |
Why?
|
Toll-Like Receptor 3 | 1 | 2007 | 9 | 0.080 |
Why?
|
Encephalitis, Herpes Simplex | 1 | 2007 | 16 | 0.080 |
Why?
|
Nucleic Acid Conformation | 1 | 2009 | 332 | 0.080 |
Why?
|
Membrane Proteins | 1 | 2014 | 1196 | 0.080 |
Why?
|
Intestines | 2 | 2023 | 411 | 0.080 |
Why?
|
Fluorescent Dyes | 1 | 2009 | 242 | 0.080 |
Why?
|
Disease Outbreaks | 1 | 2008 | 154 | 0.080 |
Why?
|
Europe | 2 | 2022 | 309 | 0.070 |
Why?
|
Sheep | 2 | 2017 | 239 | 0.070 |
Why?
|
Homeostasis | 2 | 2020 | 409 | 0.070 |
Why?
|
Mannose-Binding Lectin | 1 | 2006 | 3 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 879 | 0.070 |
Why?
|
Pakistan | 1 | 2006 | 15 | 0.070 |
Why?
|
Arylamine N-Acetyltransferase | 1 | 2006 | 11 | 0.070 |
Why?
|
Molecular Epidemiology | 1 | 2006 | 53 | 0.070 |
Why?
|
Africa, Central | 2 | 2017 | 4 | 0.070 |
Why?
|
Lectins | 1 | 2006 | 84 | 0.070 |
Why?
|
Genes, Bacterial | 1 | 2006 | 198 | 0.070 |
Why?
|
Reproducibility of Results | 3 | 2018 | 2705 | 0.070 |
Why?
|
Adolescent | 4 | 2017 | 8982 | 0.070 |
Why?
|
Isoenzymes | 1 | 2006 | 271 | 0.060 |
Why?
|
Genetic Speciation | 1 | 2006 | 113 | 0.060 |
Why?
|
Herpesvirus 1, Human | 1 | 2007 | 244 | 0.060 |
Why?
|
Proteome | 2 | 2018 | 124 | 0.060 |
Why?
|
Mice, Transgenic | 2 | 2020 | 1540 | 0.060 |
Why?
|
Africa | 2 | 2018 | 98 | 0.060 |
Why?
|
Noncommunicable Diseases | 1 | 2024 | 5 | 0.060 |
Why?
|
Aged | 4 | 2021 | 18415 | 0.060 |
Why?
|
Genetic Association Studies | 2 | 2017 | 294 | 0.060 |
Why?
|
Biological Assay | 1 | 2024 | 78 | 0.060 |
Why?
|
Organoids | 1 | 2023 | 61 | 0.060 |
Why?
|
Interferon-alpha | 1 | 2024 | 233 | 0.060 |
Why?
|
Actinobacillus | 1 | 2023 | 3 | 0.060 |
Why?
|
Prostaglandins E | 1 | 2023 | 19 | 0.060 |
Why?
|
Arachidonate 15-Lipoxygenase | 1 | 2023 | 15 | 0.060 |
Why?
|
Denmark | 1 | 2022 | 15 | 0.060 |
Why?
|
London | 1 | 2022 | 16 | 0.060 |
Why?
|
Virulence | 1 | 2024 | 271 | 0.060 |
Why?
|
Aminopeptidases | 1 | 2022 | 17 | 0.060 |
Why?
|
Arachidonate 12-Lipoxygenase | 1 | 2023 | 23 | 0.060 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2014 | 416 | 0.050 |
Why?
|
Immunity, Mucosal | 1 | 2023 | 69 | 0.050 |
Why?
|
Datasets as Topic | 1 | 2022 | 71 | 0.050 |
Why?
|
Acute Lung Injury | 1 | 2023 | 60 | 0.050 |
Why?
|
Interleukin-17 | 1 | 2023 | 101 | 0.050 |
Why?
|
Lymphocytic choriomeningitis virus | 1 | 2021 | 13 | 0.050 |
Why?
|
Molecular Weight | 1 | 2022 | 332 | 0.050 |
Why?
|
Autoantibodies | 1 | 2023 | 267 | 0.050 |
Why?
|
Bone Marrow | 1 | 2023 | 435 | 0.050 |
Why?
|
Down-Regulation | 2 | 2017 | 504 | 0.050 |
Why?
|
Anti-Retroviral Agents | 1 | 2021 | 30 | 0.050 |
Why?
|
Cell Division | 1 | 2023 | 696 | 0.050 |
Why?
|
Animals, Newborn | 1 | 2023 | 510 | 0.050 |
Why?
|
Viral Load | 1 | 2021 | 148 | 0.050 |
Why?
|
Fibroblasts | 2 | 2018 | 729 | 0.050 |
Why?
|
Mice, Knockout | 2 | 2016 | 1924 | 0.050 |
Why?
|
Butyric Acid | 1 | 2020 | 11 | 0.050 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2020 | 13 | 0.050 |
Why?
|
Africa South of the Sahara | 2 | 2011 | 21 | 0.050 |
Why?
|
Myeloid Cells | 1 | 2020 | 98 | 0.050 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 134 | 0.050 |
Why?
|
Ligands | 1 | 2021 | 433 | 0.050 |
Why?
|
Receptors, Interleukin-15 | 1 | 2019 | 8 | 0.050 |
Why?
|
Cohort Studies | 1 | 2006 | 2767 | 0.050 |
Why?
|
Hierarchy, Social | 1 | 2019 | 12 | 0.050 |
Why?
|
Gabon | 1 | 2019 | 1 | 0.040 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2020 | 85 | 0.040 |
Why?
|
Cameroon | 1 | 2019 | 14 | 0.040 |
Why?
|
History, Ancient | 2 | 2010 | 74 | 0.040 |
Why?
|
Primary Cell Culture | 1 | 2019 | 72 | 0.040 |
Why?
|
Risk Factors | 2 | 2011 | 5417 | 0.040 |
Why?
|
Cellular Reprogramming | 1 | 2019 | 37 | 0.040 |
Why?
|
Duodenum | 1 | 2019 | 100 | 0.040 |
Why?
|
Social Stigma | 1 | 2019 | 52 | 0.040 |
Why?
|
Butyrophilins | 1 | 2019 | 22 | 0.040 |
Why?
|
Intraepithelial Lymphocytes | 1 | 2019 | 16 | 0.040 |
Why?
|
K562 Cells | 1 | 2018 | 43 | 0.040 |
Why?
|
Pre-Exposure Prophylaxis | 1 | 2021 | 137 | 0.040 |
Why?
|
Dermis | 1 | 2018 | 27 | 0.040 |
Why?
|
Age Factors | 2 | 2014 | 1851 | 0.040 |
Why?
|
Diet, Gluten-Free | 1 | 2019 | 52 | 0.040 |
Why?
|
Lactobacillus | 1 | 2018 | 21 | 0.040 |
Why?
|
Microfilament Proteins | 1 | 2020 | 208 | 0.040 |
Why?
|
Penetrance | 1 | 2018 | 44 | 0.040 |
Why?
|
Linkage Disequilibrium | 2 | 2013 | 473 | 0.040 |
Why?
|
Germ-Free Life | 1 | 2018 | 69 | 0.040 |
Why?
|
Permeability | 1 | 2018 | 137 | 0.040 |
Why?
|
Dioxygenases | 1 | 2018 | 74 | 0.040 |
Why?
|
Syndrome | 1 | 2018 | 446 | 0.040 |
Why?
|
Receptors, Glucocorticoid | 1 | 2018 | 120 | 0.040 |
Why?
|
Indicators and Reagents | 1 | 2017 | 72 | 0.040 |
Why?
|
Reoviridae | 1 | 2017 | 6 | 0.040 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2017 | 20 | 0.040 |
Why?
|
RNA, Bacterial | 1 | 2017 | 108 | 0.040 |
Why?
|
Liver X Receptors | 1 | 2016 | 12 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2018 | 256 | 0.040 |
Why?
|
Freeze Drying | 1 | 2016 | 14 | 0.040 |
Why?
|
North America | 1 | 2017 | 180 | 0.040 |
Why?
|
Healthy Volunteers | 1 | 2017 | 143 | 0.040 |
Why?
|
Microbial Viability | 1 | 2016 | 31 | 0.040 |
Why?
|
Inflammation Mediators | 1 | 2017 | 154 | 0.040 |
Why?
|
Amino Acid Sequence | 2 | 2014 | 2062 | 0.040 |
Why?
|
Speech | 1 | 2017 | 84 | 0.040 |
Why?
|
Interleukin-1beta | 1 | 2016 | 78 | 0.040 |
Why?
|
Genetic Engineering | 1 | 2017 | 114 | 0.040 |
Why?
|
Fetus | 1 | 2017 | 226 | 0.040 |
Why?
|
Potassium Channels | 1 | 2018 | 340 | 0.040 |
Why?
|
Repressor Proteins | 1 | 2019 | 403 | 0.030 |
Why?
|
NF-kappa B | 1 | 2019 | 444 | 0.030 |
Why?
|
Genes | 2 | 2008 | 305 | 0.030 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2016 | 47 | 0.030 |
Why?
|
DNA | 1 | 2022 | 1294 | 0.030 |
Why?
|
Phospholipase D | 1 | 2015 | 12 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2021 | 1801 | 0.030 |
Why?
|
Lipids | 1 | 2017 | 269 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2016 | 270 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2016 | 214 | 0.030 |
Why?
|
Genetic Diseases, Inborn | 1 | 2016 | 101 | 0.030 |
Why?
|
Models, Animal | 1 | 2016 | 263 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2016 | 217 | 0.030 |
Why?
|
Communicable Diseases, Emerging | 1 | 2014 | 13 | 0.030 |
Why?
|
Disease Reservoirs | 1 | 2014 | 22 | 0.030 |
Why?
|
Up-Regulation | 1 | 2017 | 712 | 0.030 |
Why?
|
Africa, Western | 1 | 2014 | 10 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2015 | 351 | 0.030 |
Why?
|
DNA, Bacterial | 1 | 2015 | 236 | 0.030 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2014 | 93 | 0.030 |
Why?
|
Cytokines | 1 | 2017 | 776 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2014 | 268 | 0.030 |
Why?
|
Amino Acids | 1 | 2014 | 252 | 0.030 |
Why?
|
Morocco | 1 | 2013 | 16 | 0.030 |
Why?
|
Madagascar | 1 | 2013 | 27 | 0.030 |
Why?
|
Dogs | 1 | 2014 | 685 | 0.030 |
Why?
|
Detergents | 1 | 2012 | 34 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2014 | 260 | 0.030 |
Why?
|
Endoplasmic Reticulum | 1 | 2014 | 250 | 0.030 |
Why?
|
Blotting, Western | 1 | 2014 | 782 | 0.030 |
Why?
|
Skull | 1 | 2014 | 249 | 0.030 |
Why?
|
Body Mass Index | 1 | 2015 | 770 | 0.030 |
Why?
|
Mycobacterium Infections | 1 | 2011 | 15 | 0.020 |
Why?
|
Biomarkers | 1 | 2017 | 1718 | 0.020 |
Why?
|
Child, Preschool | 2 | 2008 | 3613 | 0.020 |
Why?
|
History | 1 | 2010 | 2 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2017 | 2232 | 0.020 |
Why?
|
Emigration and Immigration | 1 | 2010 | 48 | 0.020 |
Why?
|
Child | 2 | 2013 | 6928 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2011 | 912 | 0.020 |
Why?
|
Peptides | 1 | 2012 | 639 | 0.020 |
Why?
|
Obesity | 1 | 2015 | 963 | 0.020 |
Why?
|
Receptors, Pituitary Hormone-Regulating Hormone | 1 | 2008 | 2 | 0.020 |
Why?
|
Sequence Homology | 1 | 2008 | 28 | 0.020 |
Why?
|
Receptors, Neuropeptide | 1 | 2008 | 7 | 0.020 |
Why?
|
Spain | 1 | 2008 | 33 | 0.020 |
Why?
|
Untranslated Regions | 1 | 2008 | 19 | 0.020 |
Why?
|
Serum | 1 | 2008 | 25 | 0.020 |
Why?
|
Cricetulus | 1 | 2008 | 126 | 0.020 |
Why?
|
S Phase | 1 | 2008 | 62 | 0.020 |
Why?
|
Cyclin D1 | 1 | 2008 | 83 | 0.020 |
Why?
|
CHO Cells | 1 | 2008 | 187 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2008 | 74 | 0.020 |
Why?
|
Poly I-C | 1 | 2007 | 16 | 0.020 |
Why?
|
China | 1 | 2008 | 228 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 115 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2007 | 117 | 0.020 |
Why?
|
Organ Specificity | 1 | 2008 | 258 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2008 | 120 | 0.020 |
Why?
|
Cyclic AMP | 1 | 2008 | 273 | 0.020 |
Why?
|
Cricetinae | 1 | 2008 | 560 | 0.020 |
Why?
|
RNA, Viral | 1 | 2008 | 327 | 0.020 |
Why?
|
Computer Simulation | 1 | 2011 | 1078 | 0.020 |
Why?
|
Keratinocytes | 1 | 2007 | 143 | 0.020 |
Why?
|
Heterozygote | 1 | 2007 | 365 | 0.020 |
Why?
|
Odds Ratio | 1 | 2008 | 678 | 0.020 |
Why?
|
Mutagenesis | 1 | 2006 | 199 | 0.020 |
Why?
|
Acetylation | 1 | 2006 | 121 | 0.020 |
Why?
|
Phosphorylation | 1 | 2008 | 1106 | 0.020 |
Why?
|
Genetic Markers | 1 | 2006 | 476 | 0.020 |
Why?
|
Geography | 1 | 2006 | 223 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2008 | 482 | 0.020 |
Why?
|
Time Factors | 1 | 2012 | 5210 | 0.010 |
Why?
|
Rats | 1 | 2008 | 3990 | 0.010 |
Why?
|
Infant | 1 | 2007 | 3047 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2006 | 864 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2013 | 8491 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2008 | 6509 | 0.010 |
Why?
|